Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Foghorn Therapeutics Inc. | d105868dex312.htm |
| 10-K/A - 10-K/A - Foghorn Therapeutics Inc. | d105868d10ka.htm |
Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Adrian Gottschalk, certify that:
| 1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Foghorn Therapeutics Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
Date: April 29, 2021
| /s/ Adrian Gottschalk |
| Adrian Gottschalk |
| President, Chief Executive Officer and Director (Principal Executive Officer) |